Last year we named video game addiction the biggest mass tort of 2025. Twelve months later that call has matured into something larger: an entire generation of platform-liability litigation built on the design-defect framework, running alongside pharmaceutical and toxic torts hitting resolution milestones that reset their economics. Here is where we see the biggest opportunities of 2026, ranked by the combination of litigation momentum, claimant supply, and acquisition economics that actually determines what a tort is worth to a plaintiff firm.
1. Platform child safety: Roblox and Discord
No category moved faster in the first half of 2026. Roblox has now settled with five states — including a $15 million South Dakota agreement in July — and committed to mandatory age verification, while the private MDL continues to grow independently of those deals. Discord entered the enforcement era the same month, with a Texas court ordering age-assurance and default safety measures within 90 days. Every settlement and injunction is a public acknowledgment of the safety gap at the center of the private claims, and each one drives a measurable spike in parent search behavior. See our full breakdowns of Roblox child safety and Discord child safety.
2. Social media addiction: the bellwether era
The tort that built the design-defect playbook is now testing it in front of juries, with bellwether activity producing plaintiff-side results that reframe settlement conversations across the docket. For firms, the calculus has shifted from whether these cases survive to how large the resolved docket becomes — and awareness among parents is effectively universal. Our social media youth harm page covers current intake criteria.
3. Talc: a $5.5 billion reset
Johnson & Johnson's $5.5 billion settlement announcement in July 2026 — landing as the MDL court pressed tens of thousands of claimants on case support — resets the board for the largest personal-injury docket in the country. Resolution milestones of this scale historically improve acquisition efficiency: claimants act when an outcome feels tangible. Current criteria are on our talc litigation page.
4. Video game addiction: last year's pick, maturing on schedule
Our 2025 headline tort did what early behavioral torts do when the framework holds: case volume grew, gaming disorder diagnoses kept expanding the documented claimant pool, and the parent audience that powers acquisition became even more convinced by lived experience. It remains one of the strongest advertising foundations in mass torts — now with the benefit of a maturing docket. Full analysis on our video game addiction page.
5. Sports betting addiction: the next behavioral frontier
The design-defect framework's next application is already filing: claims that online sportsbooks identified problem gamblers from their own behavioral data and deployed VIP programs and re-engagement mechanics against them. The exposed population grows with every state that legalizes online wagering, and the docket is early enough that acquisition is essentially uncontested. See sports betting addiction.
6. The early-position sleepers: Dupixent and Oxbryta
Two pharmaceutical dockets reward firms willing to move before the crowd. Dupixent filings allege the blockbuster eczema biologic masked or accelerated cutaneous T-cell lymphoma in misdiagnosed patients — a ground-floor tort with an enormous treated population. Oxbryta carries the cleanest liability signal a pharma tort can offer: Pfizer's voluntary worldwide withdrawal after the data showed the drug's risks outweighed its benefit. Breakdowns on our Dupixent and Oxbryta pages.
What this ranking means for your firm
The pattern across 2026 is unmistakable: behavioral and platform torts supply the volume, resolution milestones in mature dockets like talc supply the urgency, and early pharma positions supply the asymmetric upside. The firms winning this year are running portfolios across all three — and buying cases in the early torts while the advertising is still cheap. For live per-tort market data, see our mass tort market data page, and our full tort index covers intake criteria for every litigation we run.
Mass Tort Ad Agency is a plaintiff-side advertising agency, not a law firm. Nothing in this article is legal advice.
